|
"ling wei hsin"的相關文件
顯示項目 41-65 / 70 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-07-07T05:13:03Z |
An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans
|
Huang Y.-Y.;Chiu M.-J.;Yen R.-F.;Tsai C.-L.;Hsieh H.-Y.;Chiu C.-H.;Wu C.-H.;Ling-Wei Hsin;Tzen K.-Y.;Cheng C.-Y.;Ma K.-H.;Shiue C.-Y.; Huang Y.-Y.; Chiu M.-J.; Yen R.-F.; Tsai C.-L.; Hsieh H.-Y.; Chiu C.-H.; Wu C.-H.; LING-WEI HSIN; Tzen K.-Y.; Cheng C.-Y.; Ma K.-H.; Shiue C.-Y. |
| 臺大學術典藏 |
2021-07-07T05:13:02Z |
Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use
|
Shih K.-T.; Huang Y.-Y.; Yang C.-Y.; Cheng M.-F.; Tien Y.-W.; Shiue C.-Y.; Yen R.-F.; LING-WEI HSIN |
| 臺大學術典藏 |
2021-07-07T05:13:02Z |
Synthesis and evaluation of 2-(2′-((dimethylamino)methyl)-4′-(2-fluoroethoxy-substituted)phenylthio)benzenamine derivatives as potential positron emission tomography imaging agents for serotonin transporters
|
Huang Y.-Y.; Chang L.-T.; Shen H.-Y.; Chen Y.-H.; Tzen K.-Y.; Shiue C.-Y.; LING-WEI HSIN |
| 臺大學術典藏 |
2021-07-07T05:13:01Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng C.; Li Y.-H.; Yu C.-W.; Cheng Z.-H.; Liu J.-R.; Hsu J.-L.; LING-WEI HSIN; Huang C.-T.; Juan H.-F.; Chern J.-W.; Cheng Y.-S. |
| 臺大學術典藏 |
2021-07-07T05:13:00Z |
Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors
|
Hsu K.-C.; Chu J.-C.; Tseng H.-J.; Liu C.-I.; Wang H.-C.; Lin T.E.; Lee H.-S.; LING-WEI HSIN; Wang A.H.-J.; Lin C.-H.; Huang W.-J. |
| 臺大學術典藏 |
2021-05-21T11:40:45Z |
Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors
|
Hsu, Kai Cheng; Chu, Jung Chun; Tseng, Hui Ju; Liu, Chia I.; Wang, Hao Ching; Lin, Tony Eight; Lee, Hong Sheng; LING-WEI HSIN; Wang, Andrew H.J.; Lin, Chien Huang; Huang, Wei Jan |
| 臺大學術典藏 |
2021-04-21T23:29:40Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng, Cheng; Li, Yu Hsuan; CHAO-WU YU; Cheng, Ze Hua; Liu, Jia Rong; Hsu, Jui Ling; LING-WEI HSIN; Huang, Chen Tsung; HSUEH-FEN JUAN; JI-WANG CHERN; YI-SHENG CHENG |
| 臺大學術典藏 |
2021-01-18T09:11:54Z |
Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use
|
Shih, Kai Ting; YA-YAO HUANG; Yang, Chia Ying; MEI-FANG CHENG; YU-WEN TIEN; Shiue, Chyng Yann; Yen, Rouh Fang; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T07:20:53Z |
Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1- [2- [bis (4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents
|
Lewis, D.B.;Matecka, D.;Zhang, Y.;Hsin, L.-W.;Dersch, C.M.;Stafford, D.;Glowa, J.R.;Rothman, R.B.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T06:55:29Z |
Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone-amino acid conjugates
|
Hsin, L.-W.;Wang, H.-P.;Kao, P.-H.;Lee, O.;Chen, W.-R.;Chen, H.-W.;Guh, J.-H.;Chan, Y.-L.;His, C.-P.;Yang, M.-S.;Li, T.-K.;Lee, C.-H.; LING-WEI HSIN; JIH-HWA GUH; TSAI-KUN LI |
| 臺大學術典藏 |
2018-09-10T05:45:17Z |
Novel radical synthesis of morphine fragments spiro[benzofuran-3(2H),4'-piperidine] and octahydro-1H-benzofuro[3,2-e]isoquinoline
|
Cheng, C.-Y.;Hsin, L.-W.;Liou, J.-P.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T05:45:17Z |
Synthesis of 1,4-bis [(17-normorphinyl)methyl]cubane, a morphine dimer linked by cubane
|
Cheng, C.-Y.;Hsin, L.-W.;Tao, P.-L.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T05:45:16Z |
N-Cubylmethyl substituted morphinoids as novel narcotic antagonists
|
Cheng, C.-Y.;Hsin, L.-W.;Lin, Y.-P.;Tao, P.-L.;Jong, T.-T.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T05:11:14Z |
Stereoselective synthesis of morphine fragments trans- and cis-octahydro-1H-benzo[4,5]furo[3,2-e]isoquinolines
|
Hsin, L.-W.;Chang, L.-T.;Chen, C.-W.;Hsu, C.-H.;Chen, H.-W.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T05:11:14Z |
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
|
Jutkiewicz, E.M.;Wood, S.K.;Houshyar, H.;Hsin, L.-W.;Rice, K.C.;Woods, J.H.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T05:11:13Z |
Asymmetric total synthesis of (-)-octahydro-1H-benzofuro[3,2-e] isoquinoline, a partial structure of morphine
|
Hsin, L.-W.;Chen, C.-W.;Chang, L.-T.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:42:54Z |
Synthesis of 3-[4-acyl-2-(1-methoxy-1-methylethyl)morpholin-3-yl]- benzonitriles as novel potassium channel openers
|
Lin, M.-S.;Hsin, L.-W.;Cheng, C.-Y.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:42:54Z |
Synthesis and opioid activity of 7-oxygenated 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolin-9-ols
|
Cheng, C.-Y.;Hsin, L.-W.;Tsai, M.-C.;Schmidt, W.K.;Smith, C.;William Tam, S.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:24:43Z |
A concise synthesis of (S)-(+)-1-(4-{2-[bis-(4-fluorophenyl)methoxy]-ethyl} piperazin-1-yl)-2-phenylpropan-2-ol dimaleate
|
Prisinzano, T.;Hsin, L.-W.;Folk, J.E.;Flippen-Anderson, J.L.;George, C.;Jacobson, A.E.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:24:43Z |
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents
|
Hsin, L.-W.;Prisinzano, T.;Wilkerson, C.R.;Dersch, C.M.;Horel, R.;Jacobson, A.E.;Rothman, R.B.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:24:43Z |
Synthesis of galanthamine analogs as acetylcholinesterase inhibitors via intramolecular heck cvclization
|
Liang, P.-H.;Hsin, L.-W.;Pong, S.-L.;Hsu, C.-H.;Cheng, C.-Y.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:04:49Z |
Selective reversible and irreversible ligands for the κ opioid receptor
|
Cheng, C.-Y.;Wu, S.-C.;Hsin, L.-W.;William Tam, S.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:04:48Z |
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists
|
Hsin, L.-W.;Tian, X.;Webster, E.L.;Coop, A.;Caldwell, T.M.;Jacobson, A.E.;Chrousos, G.P.;Gold, P.W.;Habib, K.E.;Ayala, A.;Eckelman, W.C.;Contoreggi, C.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:04:48Z |
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: Chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy) ethyl]-4-(3-phenylpropyl)piperazine
|
Hsin, L.-W.;Dersch, C.M.;Baumann, M.H.;Stafford, D.;Glowa, J.R.;Rothman, R.B.;Jacobson, A.E.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:04:48Z |
N-Arylated pyrrolidin-2-ones and morpholin-3-ones as potassium channel openers
|
Liang, P.-H.;Hsin, L.-W.;Cheng, C.-Y.; LING-WEI HSIN; PI-HUI LIANG |
顯示項目 41-65 / 70 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
